<?xml version="1.0" encoding="UTF-8"?>
<ack id="ak005">
 <title>Acknowledgments</title>
 <p>Authors gratefully acknowledge BITS-Pilani for providing the necessary facilities to do this work. This work was carried out under grants from the 
  <funding-source id="gp005">Department of Biotechnology Indo-Spain, New Delhi</funding-source>. (Ref. No: BT/IN/Spain/39/SM/2017-2018) and 
  <funding-source id="gp010">
   <institution-wrap>
    <institution-id institution-id-type="doi">10.13039/501100003329</institution-id>
    <institution>Ministerio de Econom√≠a y Competitividad</institution>
   </institution-wrap>
  </funding-source> (MINECO, AEI, FEDER, UE) MINECO: AGL2016-79813-C2-1R. BLT is supported by the collaborative 
  <funding-source id="gp015">Antiviral Drug Discovery and Development Center</funding-source> (AD3C) led by the 
  <funding-source id="gp020">School of Medicine University of Alabama Birmingham</funding-source> (UAB) (
  <ext-link ext-link-type="uri" xlink:href="https://www.uab.edu/medicine/ad3c/" id="ir005" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.uab.edu/medicine/ad3c/</ext-link>). The AD3C is one of the Centers of Excellence for Translational Research from the 
  <funding-source id="gp025">
   <institution-wrap>
    <institution-id institution-id-type="doi">10.13039/100000060</institution-id>
    <institution>National Institute of Allergy and Infectious Diseases</institution>
   </institution-wrap>
  </funding-source> (NIAID), funded by grant U19 AI142759.
 </p>
</ack>
